Antileishmanial agent-33
Antileishmanial agent-33 (4e), a hybrid compound of grandisin and machilin G, shows moderate activity on promastigotes (IC50 of 38.1 μM) . Antileishmanial agent-33 (4e) shows potential as an antileishmanial agent for the research of cutaneous leishmaniasis (CL) [1].
Product Specifications
UNSPSC
12352005
Target
Parasite
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Infection; Inflammation/Immunology
Smiles
COC1=C(OC)C(OC)=C(Cl)C(C2=NOC(C3=CC=C(OCO4)C4=C3)=C2)=C1
Molecular Formula
C19H16ClNO6
Molecular Weight
389.79
References & Citations
[1]Amarith R das Neves, et al. Exploring chloro-isoxazole compounds inspired on tetrahydrofuran neolignans as promising antileishmanial agents. Eur J Med Chem. 2025 Jun 5:290:117478.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
129446-ML550 100 µL
MASP1 (Mannan-binding Lectin Serine Protease 1, Complement Factor MASP-3, Complement-activating Component of Ra-reactive Factor, Mannose-binding Lectin-associated Serine Protease 1, MASP-1, RaRF, Mannose-binding Protein-associated Serine Protease, Ra-reactive Factor Serine Protease p100, Serine Protease 5, CRARF, CRARF1, PRSS5) (MaxLight 550)
Ask
View Details QP10553-10ug 10ug
Recombinant Human CKMBITI Protein, Untagged, Pichia Pastoris-10ug
Ask
View Details 
